
The study developed a predictive nomogram for assessing the success of single-dose methotrexate (MTX) treatment in tubal ectopic pregnancy. Among 372 patients, 77.9% achieved resolution with MTX. Key predictors of success included lower β-hCG levels and the absence of a yolk sac or fetal pole. The model demonstrated good accuracy and discriminative ability, offering a valuable tool for predicting MTX treatment outcomes.
Like
Save
Share